Articles by Larissa Ku
Joy sets modest target for China VC fund - update
Beijing-based Joy Capital has set a lower target for its latest US dollar-denominated fund than in the previous vintage and decided against raising a second accompanying growth vehicle.
China biotech: End of the boom
PE investment in China biotech has collapsed amid failed IPO processes and disputed valuations. Pockets of activity remain, though questions around commercialisation have yet to be answered
China RNA vaccine developer raises $42m
Therorna, a China-based biotech company specializing in vaccines and drugs based on circular RNA technology, has raised USD 42m in Series A funding.
AstraZeneca-CICC fund backs China gene sequencer
Axbio, a China-based provider of gene sequencing and diagnostic systems, has raised nearly USD 100m in Series B funding led by AstraZeneca-CICC Healthcare Industrial Fund and Yunfeng Capital.
China bio-manufacturing start-up Mojia raises $80m
Temasek Holdings has led a USD 80m Series B round for Shanghai-based bio-manufacturing start-up Mojia Biotech.
5Y leads $74m round for China AI drug developer
Beijing-based HeliXon, an artificial intelligence-enabled developer of protein-based drugs, has raised CNY 500m (USD 75m) in Series A funding led by 5Y Capital. Other investors include Gaorong Capital and Neumann Capital.
China fashion software platform Linctex raises $100m
Linctex Digital, a Shanghai-based design services platform for the fashion industry, has raised an extended pre-Series B round of nearly USD 100m from GL Ventures and CDH Investments.
China's ZWC hits first close on debut renminbi fund
Chinese venture capital firm ZWC Partners has reached the first close of CNY 1bn (USD 149m) on its debut renminbi-denominated fund. The overall target is CNY 1.5bn.
Deal focus: TH Capital identifies key niche in energy storage
Zhongchu Guoneng Technology is leading China’s push into compressed air energy storage as a means of harnessing fast-rising yet unstable wind and solar capacity. Tsinghua Holdings Capital is among the backers
Capital Today leads $40m Series B for China's XYZ Robotics
XYZ Robotics, a Chinese start-up specialising in robotic hand-eye coordination, has raised an extended Series B round of USD 40m led by Capital Today China Group.
Hillhouse reaches first close on China carbon neutrality fund
Hillhouse Capital has reached the first close on its debut renminbi-denominated carbon neutrality fund, which has an overall target of around CNY 4bn (USD 597m).
China life sciences research business gets $300m Series C
MegaRobo Technologies, a China-based provider of artificial intelligence (AI) and robotics-enabled research services to the life sciences industry, has raised USD 300m in Series C funding.
Capital Today leads $100m round for China's Hai Robotics
Hai Robotics, a China-based warehouse robot company, has raised an extended Series D round of USD100m led by Capital Today China Group.
GP profile: Future Capital
Chinese venture capital firm Future Capital bases its investments on strong networks and research as well as a fondness for founders who are not afraid to confound accepted wisdom
Monad targets up to $150m for second China software fund
Monad Ventures, a China-based VC firm specialising in early-stage enterprise software investments, is looking to raise up to USD 150m for its second US dollar-denominated fund.
China edge cloud computing provider raises $38m
Shanghai-based distributed cloud computing company PPIO has raised nearly CNY 250m (USD 37.6m) in Series A funding led by Panlin Capital, China Creation Ventures, Shanghai Zhangjiang Technology Venture Investment, and IMO Ventures.
Med-Fine leads Series A for China's Degron Therapeutics
US and China-based biotech player Degron Therapeutics has closed a USD 22m Series A round led by Med-Fine Capital.
Fengshi leads $45m Series D for China cancer diagnosis player
Singlera Genomics, a Shanghai-based cancer diagnostics specialist, has raised an extended Series B round of CNY 300m (USD 45m) led by Fengshi Investment Management.
China's Insilico Medicine gets $60m Series D
Insilico Medicine, a China-based artificial intelligence (AI)-driven drug discovery company, has raised a USD 60 million Series D round.
China machine vision company AlpsenTek raises $30m
Chinese machine vision developer AlpsenTek has raised a CNY 200m (USD 30m) Series A round led by Xunxing Investment, an arm of mobile brand Oppo, and Cowin Capital.
China autonomous driving player Minieye raises $120m
Chinese autonomous driving solutions provider Minieye has raised CNY 800m (USD 120m) in Series D funding across three tranches. The third tranche was led by Cathay Capital.
Deal focus: Hike supports Song Yao's second act
Orienspace, a Chinese rocket developer founded by the entrepreneur behind DeePhi Technology, has secured USD 60m in funding from Hike Capital and others to accelerate its launch schedule
Cathay achieves $241m first close on renminbi fund
Cathay Capital Private Equity has reached a first close of CNY 1.6bn (USD 241m) on its second renminbi-denominated growth fund.
Vision Fund, GGV back China blockchain infrastructure player
China-based blockchain infrastructure developer InfStones has received USD 66m in funding led by SoftBank Vision Fund 2 and GGV Capital. Ince Capital, 10T Fund, SNZ Holding, and A&T Capital also participated.